Copyright
©The Author(s) 2022.
World J Gastroenterol. Jul 21, 2022; 28(27): 3488-3502
Published online Jul 21, 2022. doi: 10.3748/wjg.v28.i27.3488
Published online Jul 21, 2022. doi: 10.3748/wjg.v28.i27.3488
Item | Number or range |
Nodules, n | 511 |
Patients, n | 269 |
Males, n (%) | 219 (81.4) |
Females, n (%) | 50 (18.6) |
Median age at first nodule (IQR; range) | 69 years (61-75; 43-88) |
Males (IQR; range) | 67 years (59-74; 43-88) |
Females (IQR; range) | 74.5 years (71-78; 59-85) |
Hepatic cirrhosis aetiology (n) | |
Chronic HCV infection, n (%) | 129 (48) |
Alcohol abuse, n (%) | 45 (16.7) |
Chronic HBV infection, n (%) | 24 (8.9) |
Chronic HCV infection + alcohol abuse, n (%) | 21 (7.8) |
Chronic HBV + HCV infection, n (%) | 8 (3) |
NASH, n (%) | 6 (2.2) |
ChronicHBV infection + alcohol abuse, n (%) | 5 (1.9) |
Other aetiologies, n (%) | 6 (2.2) |
Unknown aetiology, n (%) | 25 (9.3) |
Median diameter of nodules (IQR; range) | 24 mm (16-36; 5-200) |
- Citation: Vidili G, Arru M, Solinas G, Calvisi DF, Meloni P, Sauchella A, Turilli D, Fabio C, Cossu A, Madeddu G, Babudieri S, Zocco MA, Iannetti G, Di Lembo E, Delitala AP, Manetti R. Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis. World J Gastroenterol 2022; 28(27): 3488-3502
- URL: https://www.wjgnet.com/1007-9327/full/v28/i27/3488.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i27.3488